HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$1.80
Day range
$1.73 - $1.83
Year range
$1.71 - $9.69
Market cap
101.14M USD
Avg Volume
370.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 665.00K | -90.78% |
Operating expense | 110.53M | 20.88% |
Net income | -35.81M | -82.58% |
Net profit margin | -5.38K | -1,879.78% |
Earnings per share | -0.29 | -163.64% |
EBITDA | -36.00M | -79.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 290.11M | 51.06% |
Total assets | 371.12M | 36.37% |
Total liabilities | 130.15M | 7.31% |
Total equity | 240.97M | — |
Shares outstanding | 56.59M | — |
Price to book | 0.42 | — |
Return on assets | -25.52% | — |
Return on capital | -27.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -35.81M | -82.58% |
Cash from operations | -27.41M | -15.34% |
Cash from investing | 27.29M | 1,326.71% |
Cash from financing | 45.69M | 240,373.68% |
Net change in cash | 45.57M | 308.72% |
Free cash flow | -13.92M | 13.31% |
About
Founded
2018
Headquarters
Website
Employees
194
